Celerion Inc., a leading provider of clinical research services, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 1979, Celerion has established itself in the biopharmaceutical industry, specialising in early clinical research and drug development services.
The company offers a range of unique services, including bioanalytical testing, clinical pharmacology, and patient recruitment, which are designed to accelerate the drug development process. Celerion's commitment to innovation and quality has positioned it as a trusted partner for pharmaceutical and biotechnology companies worldwide. With a strong track record of successful studies and a focus on regulatory compliance, Celerion continues to play a pivotal role in advancing healthcare solutions.
0 vs industry average
Celerion Inc.’s score of 23 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Celerion Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has reduced its overall emissions by 23% since 2018
Reported emissions
No reported emissions data is available for Celerion Inc. yet.
Celerion Inc.'s reported carbon emissions
Celerion Inc., headquartered in the United States, has made significant commitments towards reducing its carbon emissions and addressing climate change. Although specific emissions data for the most recent year is not available, the company has pledged to achieve net-zero emissions by 2050. This commitment aligns with the Science Based Targets initiative (SBTi) and aims to limit global temperature rise to 1.5°C.
Celerion's long-term reduction targets encompass all scopes of emissions, reflecting a comprehensive approach to sustainability. The company is actively working towards these ambitious goals, having initiated its commitment in 2023. As part of its climate strategy, Celerion is focused on implementing measures that will contribute to significant reductions in greenhouse gas emissions across its operations.
While detailed emissions figures are currently unavailable, Celerion's proactive stance in setting long-term targets demonstrates its dedication to environmental stewardship within the pharmaceuticals, biotechnology, and life sciences sector. The company's efforts are crucial in the broader context of corporate responsibility and climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Celerion Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Celerion Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Celerion Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project